Märkte
Wertpapier | Kurs | % ▼ | Buy | Sell | Kursziel | Potential |
---|---|---|---|---|---|---|
Tetraphase Pharmaceuticals |
0,22 €
26.09.19 |
-10,67 % | 0 | 0 | - | - |
Aradigm Corp. New |
0,097 €
18.07.19 |
-12,15 % | 0 | 0 | - | - |
Qualigen Therapeutics Inc. |
0,20 €
02.08.24 |
-12,84 % | 0 | 0 | - | - |
Fortress Biotech Inc. |
0,27 €
20.11.23 |
-12,90 % | 0 | 0 | - | - |
Endo International |
0,010 €
30.04.24 |
-16,67 % | 0 | 0 | - | - |
Aravive, Inc. |
0,033 €
29.01.24 |
-16,67 % | 0 | 0 | - | - |
Sintx Technologies Inc. |
0,062 €
06.06.24 |
-16,89 % | 0 | 0 | - | - |
Seelos Therapeutics Inc. |
0,097 €
27.11.23 |
-19,49 % | 1 | 0 | - | - |
Acadia Pharmaceuticals |
13,87 €
07.08.24 |
-19,50 % | 34 | 1 | 30,43 € | 119,44 % |
Nuvectra Corp |
0,10 €
13.12.19 |
-23,08 % | 0 | 0 | - | - |
Nevro Corp. |
6,10 €
07.08.24 |
-23,27 % | 2 | 4 | 21,13 € | 246,47 % |
Heat Biologics Inc. |
0,069 €
14.06.24 |
-24,86 % | 0 | 0 | - | - |
iBio Inc. |
0,18 €
28.11.23 |
-28,52 % | 3 | 2 | 4,59 € | 2406,01 % |
Histogenics Corp. |
0,14 €
30.09.19 |
-30,94 % | 0 | 0 | - | - |
Aceragen Inc. |
0,45 €
09.10.23 |
-39,43 % | 0 | 0 | - | - |
Surgalign Holdings Inc. |
0,015 €
12.07.23 |
-39,53 % | 0 | 0 | - | - |
T2 Biosystems Inc. |
0,16 €
20.11.23 |
-44,06 % | 0 | 6 | - | - |
Immune Pharmaceuticals Inc |
0,001 €
27.07.22 |
-75,00 % | 0 | 0 | - | - |
Invitae Corp |
0,083 €
16.02.24 |
-78,84 % | 0 | 0 | - | - |
Lannett Co. Inc. |
0,015 €
03.05.23 |
-86,36 % | 0 | 0 | - | - |
Momenta Pharmaceuticals |
44,80 €
18.12.20 |
- | 0 | 0 | - | - |
Sunwin Stevia Intl. |
-
- |
- | 0 | 0 | - | - |
Dynatronics Corp |
0,42 €
25.05.23 |
- | 0 | 0 | - | - |
Alliqua BioMedical Inc |
0,050 €
27.01.22 |
- | 0 | 0 | - | - |
Varian Medical Systems Inc. |
148,60 €
24.07.21 |
- | 0 | 0 | - | - |
Antares Pharma |
5,25 €
27.08.22 |
- | 0 | 0 | - | - |
Lightpath Techs A |
1,24 €
07.08.24 |
- | 3 | 0 | 2,78 € | 124,56 % |
Cambrex Corp. |
54,00 €
03.12.19 |
- | 0 | 0 | - | - |
Lifepoint Hospitals |
-
- |
- | 0 | 0 | - | - |
VIVUS Inc |
0,41 €
02.10.20 |
- | 0 | 0 | - | - |